Sunday, August 21, 2022

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | NEJM

Compared to the primary series, booster effectiveness against symptomatic omicron infection was 49.4%, with the primary series 76.5%.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)